Showing results (51-60 of 60) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Brain Research|October 18, 1988
Electrophysiological analysis of factors involved in the primary demyelinating diseases: the rabbit eye model systemJ C Arezzo, C F Brosnan, C E Schroeder, et al.Journal of Neuroimmunology|January 1, 1988
Quantitation of antigen-specific T-cell-induced demyelination in vitroW D Lyman, G A Roth, C F Brosnan, et al.Journal of the Neurological Sciences|April 1, 1981
Experimental allergic encephalomyelitis. Characterization of serum factors causing demyelination and swelling of myelinI Grundke-Iqbal, C S Raine, A B Johnson, et al.Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|June 1, 1986
Chemical neurotoxicity: detection and analysis in organotypic cultures of sensory and motor systemsP S Spencer, S M Crain, M B Bornstein, et al.Cellular Immunology|October 1, 1986
Antigen-specific T cells can mediate demyelination in organotypic central nervous system culturesW D Lyman, G A Roth, F C Chiu, et al.Brain Research|September 21, 1979
Effects of anti-white matter serum on myelin and lipid synthesis in brain prismsE P Lapin, H S Maker, G M Lehrer, et al.Neurology|December 1, 1985
Immunogenic potentials of copolymer I in normal human lymphocytesC F Brosnan, M Litwak, P A Neighbour, et al.Neurology|April 1, 1991
A placebo-controlled, double-blind, randomized, two-center, pilot trial of Cop 1 in chronic progressive multiple sclerosisM B Bornstein, A Miller, S Slagle, et al.The New England Journal of Medicine|August 13, 1987
A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosisM B Bornstein, A Miller, S Slagle, et al.Neurology|July 1, 1988
Clinical experience with COP-1 in multiple sclerosisM B Bornstein, A Miller, S Slagle, et al.Pageof 6